Treatment of localized non-Hodgkin's lymphomas of the head and neck: Focusing on cases of non-lethal midline granuloma

Radiation Oncology Investigations

Volumn 6, Issue 4, 1998, Pages 161-169

  Sakata, Koh Ichi ^a   Hareyama, Masato ^a   Oouchi, Atushi ^a   Sido, Mitsuo ^a   Nagakura, Hisayasu ^a   Morita, Kazuo ^a   Harabuchi, Yasuaki ^a   Kataura, Akikatsu ^a   Hinoda, Yuuji ^b  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY   (Japan)

Author keywords

Chemotherapy; Head and neck; Non Hodgkin's lymphoma; Prognostic factors; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; COBALT 60; CYCLOPHOSPHAMIDE; DOXORUBICIN; METHOTREXATE; PEPLEOMYCIN; PREDNISOLONE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; FEMALE; GRANULOMA; HEAD AND NECK TUMOR; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; TREATMENT OUTCOME;

EID: 0031880661     PISSN: 10657541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6823(1998)6:4<161::AID-ROI3>3.0.CO;2-W     Document Type: Article

References (31)

1. Jacobs C, Hoppe RT: Non-Hodgkin's lymphomas of head and neck extranodal sites. Int J Radiat Oncol Biol Phys 11:357-364, 1985.
2. Mill WB, Lee FA, Franssila KO: Radiation therapy treatment of stage I and II extranodal non-Hodgkin's lymphoma of the head and neck. Cancer 45:653-661, 1980.
3. Shimm DS, Dosoretz DE, Harris NL, Pilch BZ, Linggood RM, Wang CC: Radiation therapy of Waldeyer's ring lymphoma. Cancer 54:426-431, 1984.
4. Bajetta E, Valagussa P, Bonadonna G, Lattuada A, Buzzoni R, Rilke F, Banfi A: Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy. Int J Radiat Oncol Biol Phys 15:3-12, 1988.
5. Tondini C, Zanini M, Lombardi F, Bengala C, Rocca A, Giardini R, Buzzoni R, Valagussa P, Bonadonna G: Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. J Clin Oncol 11:720-725, 1993.
6. Bartlett NL, Kwak LW, Homing SJ: MACOP-B +/-radiation therapy for diffuse large cell lymphoma. Analysis of the Stanford results according to prognostic indices. Cancer 71:4034-1042, 1993.
7. Prestidge BR, Horning SJ, Hoppe RT: Combined modality therapy for stage I-II large cell lymphoma. Int J Radiat Oncol Biol Phys 15:633-639, 1988.
8. Fuller LM, Krasin MJ, Velasquez WS, Allen PK, McLaughlin P, Rodriguez MA, Hagemeister FB, Swan F, Jr., Cabanillas F, Palmer JL, et al.: Significance of tumor size and radiation dose to local control in stage I-III diffuse large cell lymphoma treated with CHOP-Bleo and radiation [see comments]. Int J Radiat Oncol Biol Phys 31:3-11, 1995.
9. Connors JM, Klimo P, Fairey RN, Voss N: Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. Ann Intern Med 107:25-30, 1987.
10. Rudders RA, Ross ME, DeLellis RA: Primary extranodal lymphoma: Response to treatment and factors influencing prognosis. Cancer 42:406-416, 1978.
11. Ruijs CD, Dekker AW, van Kempen Harteveld ML, van Baarlen J, Hordijk GJ: Treatment of localized non-Hodgkin's lymphomas of the head and neck. Cancer 74:703-707, 1994.
12. Shigematsu N, Kondo M, Mikata A: Prognostic factors of stage I and II non-Hodgkin's lymphomas of the head and neck: The value of the working formulation and need for chemotherapy. Int J Radiat Oncol Biol Phys 15:1111-1118, 1988.
13. NCI: National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 49:2112-2135, 1982.
14. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860-1861, 1971.
15. Lymphoma: Combination chemotherapy with vincristine, cyclophosphamide (Endoxan), prednisolone and adriamycine (VEPA) in advanced adult non-Hodgkin's lymphoid malignancies: Relation between T-cell or non-T-cell phenotype and response. Jpn J Clin Oncol 9:397-106, 1979.
16. Kaplan EL, Meier P: Non-parametric estimates from incomplete observations. J Am Stat Assoc 53:457-480, 1953.
17. Cox DR: Regression models and life tables. J R Stat Soc [B] 34:187-220, 1972.
18. Itami J, Itami M, Mikata A, Tamaru J, Kaneko T, Ogata H, Uno K, Arimizu N: Non-Hodgkin's lymphoma confined to the nasal cavity: Its relationship to polymorphic reticulosis and results of radiation therapy. Int J Radiat Oncol Biol Phys 20:797-802, 1991.
19. Sakata K, Hareyama M, Ohuchi A, Sido M, Nagakura H, Morita K, Harabuchi Y, Kataura A: Treatment of lethal midline granuloma type nasal T-cell lymphoma. Acta Oncol 36:307-311, 1997.
20. Eichel BS, Harrison EG, Devine KD, Scanlon PW, Brown HA: Primary lymphoma of the nose including a relationship to lethal midline granuloma. Am J Surg 112:597-605, 1966.
21. Ng CS, Chan JK, Lo ST: Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum Pathol 18:1257-1262, 1987.
22. Yamane T, Nakao Y, Yasui Y, Ota K, Ohira H, Inoue T, Furukawa Y, Hiyoshi M, Sasaki A, Kishida T, et al.: Evaluation of 117 patients with non-Hodgkin's lymphoma in the past ten years at our department. Osaka City Med J 36:149-160, 1990.
23. Cabanillas F, Bodey GP, Freireich EJ: Management with chemotherapy only of stage I and II malignant lymphoma of aggressive histologic types. Cancer 46: 2356-2359, 1980.
24. Longo DL, Glatstein E, Duffey PL, Ihde DC, Hubbard SM, Fisher RI, Jaffe ES, Gilliom M, Young RC, DeVita VT, Jr.: Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy. J Clin Oncol 7:1295-1302, 1989.
25. Shipp MA, Klatt MM, Yeap B, Jochelson MS, Mauch PM, Rosenthal DS, Skarin AT, Canellos GP: Patterns of relapse in large-cell lymphoma patients with bulk disease: Implications for the use of adjuvant radiation therapy. J Clin Oncol 7:613-618, 1989.
26. Jones SE, Miller TP, Connors JM: Long-term follow-up and analysis for prognostic factors for patients with limited-stage diffuse large-cell lymphoma treated with initial chemotherapy with or without adjuvant radiotherapy [see comments]. J Clin Oncol 7:1186-1191, 1989.
27. Mauch P, Leonard R, Skarin A, Rosenthal D, Come S, Chaffey J, Hellman S, Canellos G: Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. J Clin Oncol 3:1301-1308, 1985.
28. Coiffier B, Lepage E: Prognosis of aggressive lymphomas: a study of five prognostic models with patients included in the LNH-84 regimen. Blood 74:558-564, 1989.
29. Vose JM, Armitage JO, Weisenburger DD, Bierman PJ, Sorensen S, Hutchins M, Moravec DF, Howe D, Dowling MD, Mailliard J, et al.: The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma. J Clin Oncol 6: 1838-1844, 1988.
30. Monfardini S, Banfi A, Bonadonna G, Rilke F, Milani F, Valagussa P, Lattuada A: Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 6:125-134, 1980.
31. Miller TP, Jones SE: Initial chemotherapy for clinically localized lymphomas of unfavorable histology. Blood 62:413-418, 1983.